首页|Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway

Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
Objective:Hepatic fibrosis has been widely considered as a conjoint consequence of almost all chronic liver diseases.Chuanxiong Rhizoma(Chuanxiong in Chinese,CX)is a traditional Chinese herbal product to prevent cerebrovascular,gynecologic and hepatic diseases.Our previous study found that CX extracts significantly reduced collagen contraction force of hepatic stellate cells(HSCs).Here,this study aimed to compare the protection of different CX extracts on bile duct ligation(BDL)-induced liver fibrosis and investigate plausible underlying mechanisms.Methods:The active compounds of CX extracts were identified by high performance liquid chromatogra-phy(HPLC).Network pharmacology was used to determine potential targets of CX against hepatic fibro-sis.Bile duct hyperplasia and liver fibrosis were evaluated by serologic testing and histopathological evaluation.The expression of targets of interest was determined by quantitative real-time PCR(qPCR)and Western blot.Results:Different CX extracts were identified by tetramethylpyrazine,ferulic acid and senkyunolide A.Based on the network pharmacological analysis,42 overlap targets were obtained via merging the can-didates targets of CX and liver fibrosis.Different aqueous,alkaloid and phthalide extracts of CX(CXAE,CXAL and CXPHL)significantly inhibited diffuse severe bile duct hyperplasia and thus suppressed hepatic fibrosis by decreasing CCCTC binding factor(CTCF)-c-MYC-long non-coding RNA H19(H1 9)pathway in the BDL-induced mouse model.Meanwhile,CX extracts,especially CXAL and CXPHL also suppressed CTCF-c-MYC-H19 pathway and inhibited ductular reaction in cholangiocytes stimulated with tauro-cholate acid(TCA),lithocholic acid(LCA)and transforming growth factor beta(TGF-β),as illustrated by decreased bile duct proliferation markers.Conclusion:Our data supported that different CX extracts,especially CXAL and CXPHL significantly allevi-ated hepatic fibrosis and bile duct hyperplasia via inhibiting CTCF-c-MYC-H19 pathway,providing novel insights into the anti-fibrotic mechanism of CX.

Chuanxiong Rhizomacholangiocytesductular reactionLigusticum chuanxiong Hort.liver fibrosislncRNA H19

Yajing Li、Fanghong Li、Mingning Ding、Zhi Ma、Shuo Li、Jiaorong Qu、Xiaojiaoyang Li

展开 >

School of Life Sciences,Beijing University of Chinese Medicine,Beijing 100029,China

School of Chinese Materia Medico,Beijing University of Chinese Medicine,Beijing 100029,China

Beijing Municipal Science &Technology CommissionNational High-Level Talents Special Support ProgramNational Key Research and Development Program on Modernization of Traditional Chinese MedicineNational Natural Science Foundation of ChinaNational Natural Science Foundation of China

72121742022YFC35021008200404582274186

2024

10.1016/j.chmed.2023.07.003

中草药(英文版)
天津药物研究院 中国医学科学院药用植物研究所

中草药(英文版)

CSTPCD
影响因子：0.6
ISSN：1674-6384
年,卷(期)：2024.16(1)
  • 34